This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Discoveries involving microbes in colon cancer could eventually drive screening methods and lead to microbial-based therapies targeting tumors.
